Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-07-02
1992-11-24
Springer, David B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514314, 546174, 546173, C07D21512, C07D21414, C07D40307, A61K 3147
Patent
active
051662108
ABSTRACT:
Quinolinyl styryl compounds and their use as pharmaceutical agents, particularly as lipoxygenase inhibitors and/or leukotriene antagonists possessing anti-inflammatory and anti-allergic properties.
Campbell Henry F.
Galemmo, Jr. Robert A.
Huang Fu-chi
Rhone-Poulenc Rorer Pharmaceuticals Inc.
Springer David B.
LandOfFree
Quinoline derivatives as antagonists of leukotriene D4 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinoline derivatives as antagonists of leukotriene D4, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinoline derivatives as antagonists of leukotriene D4 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-922125